Related Experiment Video
Updated: Aug 11, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Time course toxicogenomic profiles in CD-1 mice after nontoxic and nonlethal hepatotoxic paracetamol administration
D P Williams1, C Garcia-Allan, G Hanton
1Department of Pharmacology and Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, P.O. Box 147, Liverpool, Merseyside L69 3GE, United Kingdom. dom@liv.ac.uk
Abstract:
Adverse drug reactions are a major clinical problem. Drug-induced hepatotoxicity constitutes a large percentage of these reactions. A thorough understanding of the genetic events, specifically, the early "decision-making" processes underlying biological changes caused by drugs and metabolites, is required. To assist in the understanding of these events, we have employed the model hepatotoxin, paracetamol (APAP), and GeneChip technology to investigate global genetic events seen after nontoxic and toxic doses in the mouse. Mice were dosed [vehicle, nontoxic APAP (1 mmol/kg), and toxic APAP (3.5 mmol/kg)], and individual hepatic RNA samples were hybridized to separate chips to determine interanimal variation. Statistical analysis detected 175 CD-1 mouse genes that were significantly regulated (P < 4.1 x 10(-6)), and nonsignificant genes were discarded. For clarity, the significantly regulated genes were then binned into categories according to their major function-antioxidant, glutathione, metabolism, transcription, immune, and apoptosis. There was no hepatic stress observed after dosing 1 mmol/kg APAP, when measured by serum alanine aminotransferase levels. Hepatic toxicity was observed at both 4 and 24 h after a 3.5 mmol/kg dose of APAP. Time course expression profiles for selected genes have been created. These results demonstrate that most active gene expression occurs around 4 h after a toxic dose of APAP. Down-regulation of these genes is observed over 24 h, coinciding with the development of overt toxicity. These data provide a deeper understanding of the in vivo time course of physiological responses of the liver to chemical stress and provide a logical step forward for the investigation of new chemical entities demonstrated positive in chemically reactive metabolite screens. The complete data set can be viewed at http://www.ebi.ac.uk/arrayexpress/. The accession number is E-MEXP-82.
Insights
Drug-induced liver injury is a significant clinical issue. This study used GeneChip technology to analyze gene expression changes in mice after paracetamol (APAP) exposure, revealing key genetic events underlying hepatotoxicity.
Area of Science:
- Toxicology
- Genomics
- Hepatology
Background:
- Adverse drug reactions, particularly drug-induced hepatotoxicity, pose a major clinical challenge.
- Understanding the early genetic events in drug-induced biological changes is crucial for mitigating these reactions.
Purpose of the Study:
- To investigate global genetic events in mouse liver following non-toxic and toxic doses of paracetamol (APAP).
- To identify early "decision-making" genetic processes involved in drug-induced hepatotoxicity.
Main Methods:
- Utilized GeneChip technology to analyze hepatic RNA from mice treated with vehicle, non-toxic APAP (1 mmol/kg), or toxic APAP (3.5 mmol/kg).
- Performed statistical analysis to identify significantly regulated genes (P < 4.1 x 10(-6)) and categorized them by function (antioxidant, glutathione, metabolism, transcription, immune, apoptosis).
- Assessed hepatic stress using serum alanine aminotransferase levels and created time-course expression profiles for selected genes.
Main Results:
- No hepatic stress was observed at the non-toxic APAP dose (1 mmol/kg).
- Hepatic toxicity manifested 4 and 24 hours after the toxic APAP dose (3.5 mmol/kg).
- Significant gene expression changes occurred around 4 hours post-toxic APAP dose, with down-regulation observed over 24 hours, coinciding with overt toxicity.
Conclusions:
- Gene expression profiling provides insights into the in vivo time course of liver responses to chemical stress.
- This study offers a foundation for investigating new chemical entities and understanding drug-induced hepatotoxicity mechanisms.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Toxicokinetics: Overview
Toxicity Testing in Animals

